No Detail Found!

Effect of Haemodialysis and Frequency of Dialysis Sessions on Serum Lipids and Biochemical Profile in Patients with Chronic Kidney Disease.

Author(s)
Shazia Tauqeer Department of Physiology, Ayub Medical College, Abbottabad, Pakistan
Raisa Naz Department of Physiology, Ayub Medical College, Abbottabad, Pakistan
Nasir Hussain Shah Kazmi Medicine, Ayub Medical College, Abbottabad, Pakistan
Muhammad Ayub Department of Physiology, AJK Medical College, Muzaffarabad, Pakistan
Abstract
Background: Different phenomenon such as loss or accumulation of various substances and dysregulation or alteration in number of metabolic pathways are responsible for aetiology and pathogenesis of chronic changes in chronic kidney disease (CKD). Haemodialysis or renal replacement therapy (RRT) does not correct the dyslipidemia of uraemia but may modify it. The objective of this study was to see the effects of haemodialysis and frequency of dialysis sessions on dyslipidemia and various biochemical markers in patients with CKD. Methods: This was a hospital based cross-sectional observational study conducted in Dialysis Unit of Ayub Teaching Hospital, Abbottabad. In our study renal functions and lipid profile of 30 healthy subjects as control group were compared with 56 cases of CKD undergoing haemodialysis with a frequency of 1, 4, 8, or 12 per moth. Serum lipid profile, renal function tests, serum and urinary albumin was estimated for both the groups. They were further analysed for serum markers before dialysis (pre-HD) and post dialysis, six months (post-HD). Statistical analysis was performed using SPSS-17. Results: Thirty (54%) subjects were males and 26 (46%) were females. The mean age of the patients was 45.48±14.78 years as against mean age of controls (46.78±13.95 years). Urea and creatinine were raised, and anaemia, hypocalcemia, hypoalbuminemia, hyponatremia, and hyperkalemia were observed. A significant elevation in serum total cholesterol, triglycerides, LDL and VLDL-C was seen. There was a reduction in HDL-C in pre-dialysis patients compared to controls. The difference between pre-HD and post-HD groups was unremarkable except for the serum potassium, chloride, urea, creatinine, total cholesterol, triglycerides and HDL-C. The effect of frequency of dialysis sessions was also not statistically significant. Conclusion: Regular treatment with dialysis may partially compensate for loss of renal function and decrease the accumulation of toxic metabolites, but cannot revert the overall physiological deficit.
Publication Details
Page(s) 3-6
DOI DOI not available
Published Journal: Pakistan Journal of Physiology, Volume: 14, Issue: 1, Year: 2018

Request the full text from PASTIC

References
CibulkaR,RacekJ,VeselaE., 2005.The importance of L-carnitine in patients with chronic renal failure treated with hemodialysis,Vnitr Lek 51 1108 -13
LeveyAS,CoreshJ,BalkE,KauszAT,LevinA,SteffesMW, 2003.National kidney foundation practice guidelines for chronic kidney disease: evaluation, classification and stratification,Ann Intern Med 139 137 -47
SalgadoJV,NevesFA,BastosMG,FrançaAK,BritoDJ,SantosEM, 2010.Monitoring renal function: measured and estimated glomerular filtration rates-a review,Braz J Med Biol Res 43 528 -36
AddabboF,MallamaciF,LeonardisD,TripepiR,TripepiG,GoligorskyMS, 2007.Searching for biomarker patterns characterizing carotid atherosclerotic burden in patients with reduced renal function,Nephrol Dial Transplant 22 3521 -6
SreenivasuluU,BhagyammaSN,AnuradhaR, 2016.Study of serum electrolyte changes in end stage renal disease patients before and after hemodialysis sessions: a hospital based study,Sch Acad J Biosci 4 283 -7
ShankaliaDM,TannaAC, 2013.Role of hemodialysis in renal failure to correct biochemical parameters,Indian J Appl Res 3 414 -6
VaranHI,DursumB,DursumE,OzbenT,SuleymanlarG, 2010.Acute effects of hemodialysis on oxidative stress parameters in chronic uremic patients: comparision of two dialysis membranes,Int J Nephrol Renovasc Dis 3 39 -45
AkdagI,YilmazY,KahveciogluS,BolcaN,ErcanI,ErsoyA, 2008.Clinical value of the malnutrition-inflammation-atherosclerosis syndrome for long-term prediction of cardiovascular mortality in patients with end-stage renal disease: A 5-year prospective study,Nephron Clin Pract 108 C99 -105
GuptaK,MahajanR, 2011.Coronary risk factors in maintenance hemodialysis patients: Who is the culprit -hemodialysis or chronic renal failure?,Int J Appl Basic Med Res 1 11 -4
JonesMK,CatteA,LiL,SegrestJP, 2009.Dynamics of activation of lecithin: cholesterol acyltransferase by apolipoprotein A-I,Biochemistry 48 11196 -210
MaheshwariN,AnsariMR,DarshanaMS,LalK,AhmedK., 2010.Pattern of lipid profile in patients on maintenance hemodialysis,Saudi J Kidney Dis Transpl 21 565 -70
ZoccaliC,KramerA,JagerKJ, 2010.Chronic kidney disease and endstage renal disease-a review produced to contribute to the report 'the status of health in the European Union: towards a healthier Europe' NDT Plus, 3 213 -24
TsimihodimosV,DounousiE,SiamopoulosKC, 2008.Dyslipidemia in chronic kidney disease: An approach to pathogenesis and treatment,Am J Nephrol 28 958 -73
RajuSSK,LalithaDL,KiranmayiP., 2013.A study of lipid profile and lipid peroxidation in chronic kidney disease with special reference to hemodialysis,J Clin Res Bioeth 4 143 -
2016.Dyslipidemia in chronic renal failure: Cause or effect?,Asian J Med Sci 7 42 -6
VaziriND,NorrisK., 2011.Lipid disorders and their relevance to outcomes in chronic kidney disease,Blood Purif 31 189 -96
AttmanPO,SamuelssonO,JohanssonAC,MoberlyJB,AlaupovicP, 2003.Dialysis modalities and dyslipidemia,Kidney Int Suppl 84 S110 -2
CibulkaR,RacekJ, 2007.Metabolic disorders in patients with chronic kidney failure,Physiol Res 56 697 -705
KaysenGA, 2006.Dyslipidemia in chronic kidney disease: Causes and consequences,Kidney Int 70 S55 -8
VaziriND, 2006.Dyslipidemia of chronic renal failure: the nature, mechanisms, and potential consequences,Am J Renal Physiol 290 262 -72
0

Citations

0

Downloads

32

Views